Table IV.
Nanoparticles | Fine particles |
---|---|
Increased bioavailability | Low bioavailability |
Dose proportionality | Potential toxic effects |
Decreased toxicity | Larger and unstable dosage form |
Smaller dosage form | Low agent surface area hence low dissolution rate |
Large agent surface area hence high dissolution rate |